Fourteen-Day Tegoprazan-Amoxicillin Dual Therapy as the First-Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial.
Qing-Zhou KongIqtida Ahmed MirzaXiaoqian ZhangXiaohui SongXiaowei LiQiumei ZhangLidong XuYuting GuoYanan YuXiu-Li ZuoYan Qing LiYue-Yue LiPublished in: Helicobacter (2024)
ClinicalTrials.gov ID: NCT05870683.